Lund, Sweden

Ingrid Teige

USPTO Granted Patents = 11 

 

Average Co-Inventor Count = 3.8

ph-index = 2

Forward Citations = 55(Granted Patents)


Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: The Innovative Mind of Ingrid Teige: Pioneering Antibody Research

Introduction: Ingrid Teige, a prominent inventor located in Lund, Sweden, has made significant strides in the field of biotechnology through her groundbreaking research and innovation. With a total of seven patents to her name, she has focused her work primarily on therapeutic applications involving antibody molecules, which hold the potential for advanced cancer treatment and management of chronic inflammatory diseases.

Latest Patents: Among her latest inventions, Teige has developed novel agonistic anti-TNFR2 antibody molecules. These unique antibodies specifically bind to TNFR2 present on target cells, thereby activating it without hindering the TNF-α ligand's ability to bind to TNFR2. This innovative approach presents promising avenues for treating various medical conditions, particularly in oncology and inflammatory disorders. Another noteworthy patent involves the combined use of FcγRIIb (CD32B) and CD20-specific antibodies. This method focuses on treating patients whose target cells exhibit elevated levels of FcγRIIb. The process entails administering an antibody that binds to a surface antigen on the target cell, combined with an agent that prevents the binding of the antibody's Fc domain to FcγRIIb, enhancing the specificity of the treatment.

Career Highlights: Ingrid Teige has garnered valuable experience throughout her career, working at notable institutions such as Kancera AB and the University of Southampton. Her work in these organizations has been instrumental in advancing her research and contributing to the wider scientific community.

Collaborations: Throughout her journey, Teige has collaborated with esteemed colleagues, including Martin John Glennie and Stephen Beers. Their combined expertise has fostered a rich environment for innovation and scientific exploration in the field of antibody therapeutics.

Conclusion: Ingrid Teige's contributions to the field of biotechnology through her innovative patents and collaborations underscore her status as a leading inventor. Her work not only enhances our understanding of antibody interactions but also promises to significantly impact the treatment landscape for cancer and chronic inflammatory diseases. Teige’s ongoing research continues to inspire future developments in medical technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…